Specifically, we have previously shown for pancreatic cancer that a combination of chemotherapy and inhibitors of both mTOR and hedgehog signaling eliminates differentiated cells as well as cancer stem cells in vitro[9], and that this translates into long-term survival in vivo. This evidence concerns the gene MTOR and familial pancreatic carcinoma.